1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801–10.
6. Eklund KK, Niemi K, Kovanen PT. Immune functions of serum amyloid A. Crit Rev Immunol 2012;32:335–48.
7. Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2–8.
8. Levi M. The coagulant response in sepsis and inflammation. Hamostaseologie 2010;30:10. –2. 14-6.
10. Gogia P, Prasad S. Utility of sequential organ failure assessment score in prognosticating sick children in pediatric intensive care unit. Int J Contemp Pediatr 2016;4:1193–6.
12. Bengnér J, Quttineh M, Gäddlin PO, Salomonsson K, Faresjö M. Serum amyloid A - a prime candidate for identification of neonatal sepsis. Clin Immunol 2021;229:108787.
15. Z Oikonomakou M, Gkentzi D, Gogos C, Akinosoglou K. Biomarkers in pediatric sepsis: a review of recent literature. Biomark Med 2020;14:895–917.
17. Donovan EK, Sienna J, Mitera G, Kumar-Tyagi N, Parpia S, Swaminath A. Single versus multifraction radiotherapy for spinal cord compression: a systematic review and meta-analysis. Radiother Oncol 2019;134:55–66.
19. Yahia S, El-Assmy MM, Eldars W, Mahmoud M, Ghaffar NA, Wahba Y. Serum amyloid A versus C-reactive protein in sepsis: new insights in an Egyptian ICU. Res Opin Anaesth Intensive Care 2019;6:429–32.
20. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 1999;37:381–8.
24. Angeletti S, Battistoni F, Fioravanti M, Bernardini S, Dicuonzo G. Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis. Clin Chem Lab Med 2013;51:1059–67.
27. Pelosi P, Barassi A, Severgnini P, Gomiero B, Finazzi S, Merlini G, et al. Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury. Chest 2008;134:101–8.
28. Cao Y, Xia Q, Chen C, Yang Y. Precursors of adrenomedullin, endothelin and atrial natriuretic peptide as diagnostic markers of neonatal infection. Acta Paediatr 2012;101:242–6.
29. Suberviola B, Castellanos-Ortega A, Llorca J, Ortiz F, Iglesias D, Prieto B. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with communityacquired pneumonia. Swiss Med Wkly 2012;142:w13542.
30. Valenzuela-Sánchez F, Valenzuela-Méndez B, Bohollo de Austria R, Rodríguez-Gutiérrez JF, Estella-García Á, Fernández-Ruiz L, et al. Plasma levels of mid-regional proadrenomedullin in sepsis are associated with risk of death. Minerva Anestesiol 2019;85:366–75.
31. Guignant C, Voirin N, Venet F, Lepape A, Monneret G. Persistent high level of circulating midregional-proadrenomedullin and increased risk of nosocomial infections after septic shock. J Trauma Acute Care Surg 2012;72:293–6.